This HTML5 document contains 35 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n8http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n10http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
n13http://linked.opendata.cz/resource/drugbank/drug/DB07784/identifier/pdb/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/resource/drugbank/drug/DB07784/identifier/pubchem-compound/
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
n9http://linked.opendata.cz/resource/drugbank/drug/DB07784/identifier/pubchem-substance/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB07784/identifier/drugbank/

Statements

Subject Item
n2:DB07784
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n8:DB07784 n10:DB07784
dcterms:title
[4-(4-ACETYLAMINO-PHENYL)-3,5-DIOXO-4-AZA-TRICYCLO[5.2.2.0 2,6]UNDEC-1-YLCARBAMOYLOXY]-ACETIC ACID
adms:identifier
n6:444144 n9:99444255 n12:DB07784 n13:FRA
n3:IUPAC-Name
n4:271B3ED5-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3EDB-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3EDA-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3ED7-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3ED8-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3ED9-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3ED3-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3ED4-363D-11E5-9242-09173F13E4C5 n4:271B3ED1-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3ED2-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3EE1-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3EE2-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3EDC-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3EDD-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3EDF-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3EDE-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3EE0-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3EE7-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3EE9-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3EEA-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3EE6-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3EE5-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3EE8-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3ED6-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3EE3-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3EE4-363D-11E5-9242-09173F13E4C5